FERRIPROX: payments to doctors
Payments that named FERRIPROX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $731K
- Providers
- 544
- Transactions
- 1,062
- Average per transaction
- $688
The per-transaction average — $688 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 544 providers the average total is $1,343, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Chiesi USA, Inc. | $708,789 | 97.0% |
| Apo-pharma Inc. | $21,334 | 2.9% |
| Apo-pharma USA, Inc. | $617 | 0.1% |